Caring Brands, Inc. Overview
Industry: Package Goods/Cosmetics
Sector: Consumer Discretionary
Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The Company intends to launch a total of 5 products over the next 2 years in addition to in-licensing additional products. Management has a successful track record of strategic acquisitions, rapid product development, IP development and product licensing. Revenues from the sales of Hair Enzyme Booster for the treatment of hair loss, and Photocil for the treatment of psoriasis and vitiligo, are currently being generated by direct sales in the US and licensees in India. Additional product opportunities include CB-101 for the treatment of eczema, NoStingz, a sunscreen that prevents jellyfish stings. Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The Company intends to launch a total of 5 products over the next 2 years in addition to in-licensing additional products. Management has a successful track record of strategic
Newly listed company coverage
Verified company profile, price history, and SEC registration source are available.
10-Q/10-K financial data, or the foreign-issuer equivalent, is not available yet.
Review the SEC registration filingResearch snapshot
This Mavefund research page organizes verified information for Caring Brands, Inc. (CABR), including the company profile, price history, source-linked filings, available financial statements, research signals, and risks to review.
- Listing
- CABR · Nasdaq · MIC XNAS
- Country
- United States
- Trading currency
- USD
- Industry
- Package Goods/Cosmetics
Primary sources
Coverage is refreshed automatically and published only after data-integrity validation. Research support only; not personalized financial advice.
Reported Results
No latest earnings report cached yet
The latest source-linked annual or interim company filing has not been cached for this ticker yet.
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
No qualified company news in the last 14 days
No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.
Financial Statements
Company-reported filing facts, organized and linked to the original source.
Annual 10-K, 20-F, or ESEF financial statement data is not available yet.
Source details load with the filing data. Values are standardized company disclosures for research support, not personalized financial advice.